tiprankstipranks
3 Best Stocks to Buy Now, 12/12/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 12/12/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

Pick the best stocks and maximize your portfolio:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Parsons (PSN) – Parsons is a technology-focused defense, intelligence, and infrastructure engineering firm. Today, Goldman Sachs analyst Noah Poponak upgraded the stock’s rating to Buy with a price target of $111. In the last three months, all eight Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 29%.

AstraZeneca (AZN) – This is a global biopharmaceutical company. Today, TD Cowen analyst Steve Scala reiterated a Buy rating on the stock with a price target of $95. In the last three months, three out of the four Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of nearly 36%.

Equifax (EFX) – Equifax is a global data analytics and credit reporting company. Today, Morgan Stanley analyst Toni Kaplan upgraded rating on the stock to Buy with a price target of $320. In the last three months, nine out of the 12 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 21%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyAstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial
TheFlyAstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecan
Go Ad-Free with Our App